Glen Eagle Advisors’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-50
Closed -$1.21K 924
2020
Q2
$1.21K Hold
50
﹤0.01% 799
2020
Q1
$876 Buy
+50
New +$876 ﹤0.01% 764